Factors associated with early hormonal therapy for prostate cancer.

被引：0
|
作者：
Kucera, G [1 ]
Yood, MU [1 ]
Demers, R [1 ]
Divine, G [1 ]
Wells, K [1 ]
Tiwari, A [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2003年 / 157卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
42
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Effects of early hormonal therapy on bone in asymptomatic men with prostate cancer.
    Bernhard, PH
    Niewoehner, C
    JOURNAL OF UROLOGY, 1998, 159 (05): : 338 - 338
  • [2] Histological effect of prolonged hormonal therapy on prostate cancer.
    Nakamoto, T
    Inoue, Y
    Asano, K
    Hayashi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 429S - 429S
  • [3] Use of hormonal therapy in men with metastatic prostate cancer.
    Lu-Yao, GL
    Moore, DF
    Dipaola, RS
    Yao, SL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
  • [4] Early hormonal therapy in prostate cancer - Reply
    Messing, EM
    Manola, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (16): : 1215 - 1216
  • [5] Chemo-hormonal therapy for biochemical progression of prostate cancer.
    Taplin, M.
    Xie, W.
    Morganstern, D.
    Bubley, G.
    Ernstoff, M.
    Regan, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 231S - 231S
  • [6] Early versus late hormonal therapy for prostate cancer
    Miyamoto H.
    Messing E.M.
    Current Urology Reports, 2004, 5 (3) : 188 - 196
  • [7] Secondary hormonal manipulation of prostate cancer.
    Harris K.A.
    Small E.J.
    Current Urology Reports, 2001, 2 (3) : 224 - 230
  • [8] Metabolic syndrome predicts for shorter response to hormonal therapy in prostate cancer.
    Flanagan, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 230S - 230S
  • [9] Patients with metastatic prostate cancer. Recommendations for primary hormonal or chemohormonal therapy
    Ohlmann, C. -H.
    UROLOGE, 2017, 56 (11): : 1424 - 1429
  • [10] Early versus delayed hormonal therapy in advanced prostate cancer
    Mazeman, E
    Bertrand, P
    EUROPEAN UROLOGY, 1996, 30 : 40 - 43
12345